RICHARD ADAMS: Open Payments
NPI 1205183993 · WAYNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 30 payments from 11 companies in 2025. Trend: 2023 $476 · 2024 $395 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| Merck Sharp & Dohme LLC | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Boston Scientific Corporation | 1 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $44 |
| AtriCure, Inc. | 1 | $38 |
| Impulse Dynamics (USA) Inc. | 3 | $37 |
| PFIZER INC. | 1 | $19 |
Products named: Repatha, JARDIANCE, Kerendia, VERQUVO, FARXIGA, WATCHMAN FLX, LifeVest, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX.
Industry payments across NJ — which companies pay providers there.
